RxDoctor Payments Data

Leslianne Grendysz

Family · Lake Ridge, VANPI 1346470598

Payments from drug & device makers

$4,871in general payments, 2019–2025

Across 233 payments — averaging $20.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$827
  • Johnson & Johnson$519
  • Scpharmaceuticals Inc.$453
  • Merck$420
  • E.r. Squibb & Sons, L.L.C.$385
  • AstraZeneca$372
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,871 in reported general payments places this provider in the 90th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan59$89,429
EliquisApixaban33$46,596
FarxigaDapagliflozin Propanediol14$21,978
XareltoRivaroxaban13$21,210
Metoprolol Succinate58$776
Atorvastatin Calcium73$501
Ezetimibe27$497
Rosuvastatin Calcium28$321
Valsartan19$298
Hydralazine Hcl24$249
Amlodipine Besylate47$216
ClopidogrelClopidogrel Bisulfate14$177
Furosemide26$159
Nebivolol Hcl16$156
Carvedilol19$145

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$827$89,42959 claims
PfizerEliquis$69$46,59633 claims
AstraZenecaFarxiga$372$21,97814 claims
Johnson & JohnsonXarelto$519$21,21013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,332 family providers in Virginia.

Other family in Lake Ridge

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →